Anzeige
Mehr »
Mittwoch, 08.07.2026 - Börsentäglich über 12.000 News
Crypto.com-Paukenschlag!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
07.07.26 | 18:02
147,90 Euro
+0,10 % +0,15
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
147,70148,0007.07.
146,90148,5007.07.

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiIs ICLR Stock a Value Trap or Turnaround After an Earnings Reset?1
26.06.ICON PLC - 6-K, Report of foreign issuer2
24.06.Biggest stock movers Wednesday: FDX, ICLR, and more9
23.06.ICON Plc Q1 Profit Retreats2
ICON Aktie jetzt für 0€ handeln
23.06.ICON plc: ICON Reports First Quarter 2026 Results471Highlights Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025. Quarter one adjusted EBITDA of $317.7 million or 15.6% of revenue. GAAP net income...
► Artikel lesen
22.06.ICON Selects Microsoft to Power AI-enabled Clinical Development6
22.06.ICON plc: ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development354ICON plc (NASDAQ: ICLR) today announced that it has selected Microsoft as a preferred technology partner further advancing ICON's previously announced plan to invest in digital innovation and AI...
► Artikel lesen
17.06.ICON PLC - 6-K, Report of foreign issuer2
17.06.ICON plc: ICON Schedules First Quarter 2026 Earnings Conference Call452ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes on Tuesday...
► Artikel lesen
08.06.ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?4
05.06.ICLR Earnings Reset: What the Accounting Probe Changed11
04.06.XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.202611.146Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation...
► Artikel lesen
27.05.ICON plc: ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation796Highlights Quarter four revenuewas $2,112.5 million. Full year revenue was $8,251 million. Quarter four adjusted EBITDA of $327.1 million or 15.5% of revenue; full year adjusted EBITDA...
► Artikel lesen
27.05.ICON PLC - 20-F, Annual and transition report of foreign private issuers2
26.05.ICON PLC - 6-K, Report of foreign issuer3
26.05.ICON plc: ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq743ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market...
► Artikel lesen
13.05.Icon Expands Early Phase Capabilities8
13.05.ICON plc: ICON expands US early phase research capabilities with new clinic and outpatient centres432New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas and...
► Artikel lesen
29.04.ICON plc: ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results766ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company's...
► Artikel lesen
29.04.ICON PLC - 6-K, Report of foreign issuer3
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1